Active substance · J07CA02
Diphtheria-pertussis-poliomyelitis-tetanus
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07C
- Chemical subgroupJ07CABacterial and viral vaccines, combined
- Chemical substanceJ07CA02Diphtheria-pertussis-poliomyelitis-tetanus
Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Diphtheria-pertussis-poliomyelitis-tetanus
Every register, a page at a time. Strengths and packs are on each medicine’s page.
19 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Triaxis Polio | Italy | Sospensione iniettabile in siringa pre-riempita | Authorised | Sanofi Winthrop Industrie | |
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Adacel®-Polio Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 5 µg/ 0.5 ml + 5 µg/0.5 ml + 3 µg/0.5 ml + 2.5 µg/ 0.5 ml + 2Lf + 40 D-Antigen Units + 8 D-antigen units + 32 D-antigen units + 5Lf | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| TetraximCombination | Saudi Arabia | Authorised | Sanofi Pasteur SA | ||
| PediacelCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| PentaximCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Infanrix Penta | European Union | Cancelled | GlaxoSmithKline Biologicals S.A. | ||
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Infanrix-Ipv+HibCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| DPT Polio Adsorbed VaccinesCombination | Canada | 25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 80 UNIT / 0.5 ML + 5 LF / 0.5 ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Tetraxim | Romania | susp. inj. in seringa preumpluta | Status unknown | Sanofi Pasteur | |
| PediacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Cancelled | Sanofi Vaccines Canada LTD. |
| PentacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Liquid, Powder For Solution | Cancelled | Sanofi Vaccines Canada LTD. |
| Boostrix-Ipv | Romania | susp. inj. in seringa preumpluta | Status unknown | Glaxosmithkline (GSK) S.R.L. | |
| QuadracelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Cancelled | Sanofi Vaccines Canada LTD. |